Article
Gamma secretase-activating protein is a substrate for caspase-3: implications for Alzheimer's disease.
Biological psychiatry - 15 Apr 2015
Chu Jin, Li Jian-Guo, Joshi Yash B, Giannopoulos Phillip F, Hoffman Nicholas E, Madesh Muniswamy, Praticò Domenico
Abstract excerpt
BACKGROUND: A major feature of Alzheimer's disease (AD) is the accumulation of amyloid-beta (Aβ), whose formation is regulated by the gamma-secretase complex and its activating protein (also known as GSAP). Because GSAP interacts with gamma-secretase without affecting the cleavage of Notch, it is an ideal target for a viable anti-Aβ therapy. However, despite much interest in this protein, the mechanisms involved...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
